Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 31 n° 301

Posts Tagged ‘market’

Global Electronic Cash Register Market 2019-2023

Posted by fidest press agency su lunedì, 14 ottobre 2019

Technavio has been monitoring the global cash register market since 2018 and the market is poised to grow by USD 4.9 billion during 2019-2023, progressing at a CAGR of almost 8% during the forecast period. The market is driven by the adoption of electronic cash registers (ECRs) by SMEs. In addition, the shift toward cloud-based solutions is anticipated to further boost the growth of the global electronic cash register market. The market has been witnessing strong demand for ECRs from SMEs over recent years. Factors such as low-cost and easy availability have increased the adoption of ECRs among end-users. SMEs in the retail and hospitality sectors are increasing the use of ECRs in terminals to ensure faster checkouts. The rise in the number of checkout terminals in the retail and hospitality industries will increase the demand for ECRs. Morevoer, the large unorganized retail sector in developing countries such as China and India is providing significant growth opportunities for market vendors. Thus, the increasing adoption of ECRs by SMEs is one of the key factors driving the growth of the global electronic cash register market.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

“Norway Automated Microbiology Market for over 100 Tests”

Posted by fidest press agency su sabato, 12 ottobre 2019

This new report from the author examines current and emerging assays; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay and application; profiles leading players and potential market entrants; and suggests alternative market penetration strategies for suppliers.
The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.
This report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Chicago Middle Market Business Conference

Posted by fidest press agency su giovedì, 10 ottobre 2019

The Chicago Middle Market Business Conference will take place on Wednesday, October 23, 2019. The conference is the best opportunity to meet and network with the leading M&A deal professionals in the Midwest. The featured panelists include leaders from the top private equity, investment banking, valuation, and legal firms presenting the latest trends and techniques in M&A. The day will commence promptly at 1:00pm with the Business Conference and conclude with the 8th annual Business Networking Reception immediately following the conference starting at 5:00pm. Both events will take place at The Standard Club in downtown Chicago.
“The Chicago Middle Market Business Conference attracts the top M&A deal professionals from around the country,” said Ted Koenig, President & CEO of Monroe Capital. “We are pleased to co-sponsor this event together with over 40 other high quality leading deal professional firms in the Midwest. This is the event’s 8th consecutive year and we are expecting well over 600 attendees in the areas of private equity, banking, investment banking, legal, accounting, tax, valuation, and M&A advisors. We look forward to a productive discussion from the panelists and a successful business networking event. It has become the highlight M&A event in the Midwest.”

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

“Educational Robots Market”

Posted by fidest press agency su martedì, 24 settembre 2019

The report predicts the global educational robots market to grow with a CAGR of 16.2% over the forecast period from 2019-2025.The report on the global educational robots market provides qualitative and quantitative analysis for the period from 2017 to 2025. The study on educational robots market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.The report on educational robots market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global educational robots market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global educational robots market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Posted in Cronaca/News | Contrassegnato da tag: , , | Leave a Comment »

Aurinia Establishes At-the-Market Facility

Posted by fidest press agency su martedì, 17 settembre 2019

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late- stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that it has entered into an Open Market Sales Agreement with Jefferies LLC (“Jefferies”) pursuant to which the Company may from time to time sell, through at-the-market (“ATM”) offerings with Jefferies acting as sales agent, such common shares as would have an aggregate offer price of up to US$40,000,000. Aurinia has also filed a prospectus supplement with securities regulatory authorities in Canada in the provinces of British Columbia, Alberta and Ontario, and with the United States Securities and Exchange Commission, which supplements Aurinia’s short form base shelf prospectus dated March 26, 2018, and Aurinia’s shelf registration statement on Form F-10 dated March 26, 2018, declared effective on March 29, 2018. The listing of any shares sold pursuant to the ATM offering is subject to the approval of the Toronto Stock Exchange and Nasdaq. Jefferies, at Aurinia’s discretion and instruction, will use its commercially reasonable efforts to sell the common shares at market prices from time to time. Sales in the ATM offering will only be conducted in the United States through Nasdaq or another exchange at market prices. No sales will be conducted in Canada or through the Toronto Stock Exchange.Aurinia currently intends to use the proceeds from sales related to the ATM offering, if any to fund its operations, which includes, but is not limited to, its dry eye syndrome program, clinical development of voclosporin, commercial production of voclosporin (whether for lupus nephritis or other indications), regulatory, pre-marketing and commercialization preparation activities for voclosporin primarily for lupus nephritis, and for general corporate purposes and working capital.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Xylem to participate in the 2019 RBC Capital Markets Global Industrials Conference

Posted by fidest press agency su venerdì, 6 settembre 2019

Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its President and CEO Patrick Decker and Senior Director of Investor Relations Matt Latino will participate in investor meetings and present at 1:30 p.m. Pacific Standard Time at the 2019 RBC Capital Markets Global Industrials Conference, at the Waldorf Astoria, Las Vegas, Nevada, on Tuesday, September 10, 2019.Xylem (XYL) is a leading global water technology company committed to developing innovative technology solutions to the world’s water challenges. The Company’s products and services move, treat, analyze, monitor and return water to the environment in public utility, industrial, residential and commercial building services settings. Xylem also provides a leading portfolio of smart metering, network technologies and advanced infrastructure analytics solutions for water, electric and gas utilities. The Company’s approximately 17,000 employees bring broad applications expertise with a strong focus on identifying comprehensive, sustainable solutions. Headquartered in Rye Brook, New York, with 2018 revenue of $5.2 billion, Xylem does business in more than 150 countries through a number of market-leading product brands.The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all – that which occurs in nature. For more information, please visit us at http://www.xylem.com.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

“India Contact Lenses Market 2019-2025”

Posted by fidest press agency su domenica, 1 settembre 2019

The report has been added to ResearchAndMarkets.com’s offering.The India contact lenses market is expected to display an upward trend and is estimated to grow at a CAGR of 7.05% in terms of revenue over the forecast duration of 2019 to 2025.The young population of India has formed a vast consumer base for contact lenses in the country. The higher adoption of contact lenses amongst consumers will also lead to increased awareness about contact lens hygiene practices.With current players investing in generating awareness regarding the usage of contact lens solutions, and new players entering, the category could grow at a great pace in the coming years. The primary restraint for the growth of the market in India is due to most Indian consumers remaining skeptical of the usage of contact lenses, and also finding it to be costlier than spectacles.The major competitors in the India contact lenses market are Purecon Lenses Pvt. Ltd., Ciba Vision Corp., Pari Vision Care Pvt. Ltd., Johnson & Johnson and Bausch & Lomb Eyecare (India) Pvt. Ltd.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

“Telecommunications Network Operators: 1Q19 Market Review”

Posted by fidest press agency su venerdì, 30 agosto 2019

This market review provides a comprehensive assessment of the global telecommunications industry based on financial results through March 2019 (1Q19). The report tracks revenue, CAPEX and employee for 130 individual telecommunications network operators (TNOs). For a sub-group of 40 large TNOs, the report also assesses labour cost, opex and operating profit trends. Our coverage timeframe spans 1Q11-1Q19 (33 quarters). The report’s format is Excel.
The global telecom industry continues to be constrained at the top line. Revenues declined YoY by 3% in 1Q19, to $456B ($1,823B annualized). Total CAPEX was $70B in 1Q19, declining at about the same rate as revenues. Labour costs were a bit higher at $72B in 1Q19.
Telcos are beginning to deploy 5G and invest in the media business, but most are doing so cautiously. Telco profit margins remain tight, nothing new for the telecom industry. Operators are getting more concerned about debt, though. The net debt (debt minus cash) of the global telco sector was roughly half of revenues in 2018, after having been in the 30-40% range of revenues at the cusp of the LTE buildout cycle. Few telcos have room in their budgets for a 5G CAPEX splurge.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Anatomic Pathology Market

Posted by fidest press agency su martedì, 20 agosto 2019

The global anatomic pathology market is projected to attain a size of $24.3 billion by 2024, progressing at a 5.8% CAGR during the forecast period.
The increasing prevalence of chronic diseases, developments in technology, and surging geriatric population are some of the major reasons behind the growth of the market. On the basis of application, the market is categorized into drug discovery, disease diagnosis, and others. Out of these, the disease diagnosis category is expected to hold the largest share of more than 65.0% in the market by 2024. This is attributed to the surging aging population and rising number of patients suffering from the chronic ailments. When segmented by end user, the anatomic pathology market is classified into diagnostic laboratories, ambulatory surgical centers, hospitals and clinics, and academic and research organizations. Among these, in 2018, diagnostic laboratories led the market with a share of 45.8%, followed by hospitals and clinics that held a 31.4% share. The reason behind this is that these laboratories are less expensive as compared to hospitals and clinics.The Asia-Pacific (APAC) anatomic pathology market is predicted to witness the fastest growth at a 6.7% CAGR during the forecast period. The key factors responsible for such rapid progress would be the acceptance of personalized medicine, growing number of chronic ailment patients, increasing investment in diagnostic research by non-government and government organizations, and entry of established players in the region. The increasing entrance rate of international players in the market is helping in better availability of advanced and innovative anatomic pathology consumables and instruments in APAC.For instance, in January 2019, Nichirei Bioscience (one of the leading suppliers of diagnostic and biological products in Japan) collaborated with Biocartis Group NV for the product registration and exclusive distribution of molecular diagnostic (MDx) oncology tests, developed by Biocartis, in Japan, which work on the sample-to-result Idylla platform, which is fully automated, Under this, Nichirei Bioscience agreed to get the regulatory approval of the Japanese Ministry of Health, Labour, and Welfare for Idylla MDx oncology tests. After the registration, Nichirei Bioscience aims to provide Biocartis’ Idylla platform to 2,000 pathology laboratories within its commercial network in Japan.
The key players operating in the anatomic pathology market are gearing up to introduce innovative solutions to improve their market presence. For instance, in February 2019, Quest Diagnostics Inc., a U.S.-based diagnostic information services provider, purchased the clinical laboratory services unit of Boyce & Bynum Pathology Laboratories (BBPL), a leading supplier of diagnostic and clinical laboratory services in the Midwest. The acquisition is aimed at offering a larger portfolio of anatomic pathology and innovative clinical laboratory services to providers and patients throughout the region.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Antiviral Therapeutics Delivery Markets

Posted by fidest press agency su sabato, 17 agosto 2019

The report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering.
This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics.The introduction starts with a practical classification of viral diseases according to their commercial importance. Various antiviral approaches are described including pharmaceuticals and molecular biological therapies such as gene therapy and RNA interference (RNAi) as well as vaccines for virus infections. Expert opinion is given about the current problems and needs in antiviral therapy. SWOT (strengths, weaknesses, opportunities and threats) analysis of antiviral approaches is presented against the background of concept of an ideal antiviral agent.A novel feature of this report is the use of nanotechnology in virology and its potential for antiviral therapeutics. Interaction of nanoparticles with viruses are described. NanoViricides are polymeric micelles, which act as nanomedicines to destroy viruses. Various methods for local as well as systemic delivery of antiviral agents and vaccines are described. Nanobiotechnology plays an important role in improving delivery of antivirals. Advantages and limitations of delivery of gene-based, antisense and RNAi antiviral therapeutics are discussed.Anti-influenza measures applicable to human as well as avian forms are described including the recent epidemic of swine flu. Resistance can develop against neuraminidase inhibitors although it is less than that with adamantanes. Considering these problems, there is need for a more effective agent. Investigations into alternative anti-influenza target will probably expand in the coming years. These include the development of mechanisms to inhibit fusion between the virus envelope and the cell membrane.After a discussion of current therapies of AIDS/HIV and their limitations, new strategies in development of antiviral agents are described. Drug resistance and toxicities are emerging as major treatment challenges. Based on a review of technologies and drugs in development, it can be stated that there are good prospects are of finding a cure for HIV/AIDS in the next decade.
Hepatitis viruses are described with focus on hepatitis C virus (HCV) and hepatitis B virus (HBV). Despite the presence of numerous drug candidates in the anti-HCV pipeline, and the commitment of major R&D resources by many pharmaceutical companies, it might still take several years for any new anti-HCV drugs to reach the market. Although many companies are focusing their efforts on developing viral inhibitors, cellular targets in the host are beginning to emerge as attractive possibilities because they might enable the development of broad-spectrum antiviral drugs with less chance for developing viral resistance.Various commercially important viruses include herpes simplex (HSV) and human papilloma virus (HPV). There a number of treatments but HSV is not destroyed completely and remains dormant and activates from time to time to cause various clinical manifestations.There is discussion about the role of HPV in cervical cancer and vaccines available now seem to be adequate in preventing HSV-induced cervical cancer. There is no effective vaccine for respiratory syncytial virus (RSV) although monoclonal antibody (MAb) treatment is useful for prophylaxis and reducing the clinical manifestations. There is a need for an agent to eliminate this virus.Various viruses that either occur in epidemics or in tropics and some naturally emerging infectious diseases are described, e.g. viral hemorrhagic fevers such as dengue and West Nile virus infection. These are a constant threat and impossible to anticipate. Some of these lack antiviral agents or vaccines for prevention. Although these include some of the most serious viral disorders, the development of antiviral agents for these is not commercially attractive. Current research and approaches to these virus infections are discussed.
Markets for antivirals are considered according to viruses and diseases caused by them and also according to management approaches: antiviral drugs, vaccines, MAbs and innovative approaches that include immunological and use of other technologies such as gene therapy, antisense, RNAi and nanobiotechnology. Antiviral markets are estimated starting with 2018 with projections up to the year 2028.Profiles of 194 companies that are involved in developing various technologies and products are profiled and with 175 collaborations. These include major pharmaceutical companies (12), Biopharmaceutical companies with antiviral products (86), Antiviral drug companies (26) as well as viral vaccine companies (71). The report is supplemented with 54 tables, 15 figures and 550 references from the literature.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Burn Care – Global Market Analysis, Trends, and Forecasts (2019-2025)

Posted by fidest press agency su sabato, 17 agosto 2019

Burn Care market worldwide is projected to grow by US$1 Million, guided by a compounded growth of 6.5%. Staying on top of trends is essential for decision makers to leverage this emerging opportunity. The report addresses this very need and provides the latest scoop on all major market segments.Advanced Burn Care, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$1.4 Million by the year 2025, Advanced Burn Care will bring in healthy gains adding significant momentum to global growth.While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 5.6% growth momentum.
Within Europe, which continues to remain an important element in the world economy, Germany will add over US$42.3 Thousand to the region’s size and clout in the next 5 to 6 years. Over US$96.6 Thousand worth of projected demand in the region will come from other emerging Eastern European markets.In Japan, Advanced Burn Care will reach a market size of US$83.6 Thousand by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9% over the next couple of years and add approximately US$251.1 Thousand in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

The “Cardiovascular Drug Delivery – Technologies, Markets & Companies”

Posted by fidest press agency su giovedì, 15 agosto 2019

The cardiovascular drug delivery markets are estimated for the years 2018 to 2028 on the basis of epidemiology and total markets for cardiovascular therapeutics.The estimates take into consideration the anticipated advances and availability of various technologies, particularly drug delivery devices in the future. Markets for drug-eluting stents are calculated separately. Role of drug delivery in developing cardiovascular markets is defined and unmet needs in cardiovascular drug delivery technologies are identified.
Drug delivery to the cardiovascular system is different from delivery to other systems because of the anatomy and physiology of the vascular system; it supplies blood and nutrients to all organs of the body. Drugs can be introduced into the vascular system for systemic effects or targeted to an organ via the regional blood supply. In addition to the usual formulations of drugs such as controlled release, devices are used as well. This report starts with an introduction to molecular cardiology and discusses its relationship to biotechnology and drug delivery systems.Drug delivery to the cardiovascular system is approached at three levels: (1) routes of drug delivery; (2) formulations; and finally (3) applications to various diseases. Formulations for drug delivery to the cardiovascular system range from controlled release preparations to delivery of proteins and peptides. Cell and gene therapies, including antisense and RNA interference, are described in full chapters as they are the most innovative methods of delivery of therapeutics. Various methods of improving systemic administration of drugs for cardiovascular disorders are described including use of nanotechnology.Cell-selective targeted drug delivery has emerged as one of the most significant areas of biomedical engineering research, to optimize the therapeutic efficacy of a drug by strictly localizing its pharmacological activity to a pathophysiologically relevant tissue system. These concepts have been applied to targeted drug delivery to the cardiovascular system. Devices for drug delivery to the cardiovascular system are also described.Role of drug delivery in various cardiovascular disorders such as myocardial ischemia, hypertension and hypercholesterolemia is discussed. Cardioprotection is also discussed. Some of the preparations and technologies are also applicable to peripheral arterial diseases. Controlled release systems are based on chronopharmacology, which deals with the effects of circadian biological rhythms on drug actions. A full chapter is devoted to drug-eluting stents as a treatment for restenosis following stenting of coronary arteries. Fifteen companies are involved in drug-eluting stents.Selected 82 companies that either develop technologies for drug delivery to the cardiovascular system or products using these technologies are profiled and 80 collaborations between companies are tabulated. The bibliography includes 200 selected references from recent literature on this topic. The report is supplemented with 31 tables and 9 figures.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

AM Best to Host Reinsurance Market Briefing at Rendez-Vous de Septembre

Posted by fidest press agency su giovedì, 15 agosto 2019

AM Best will host its annual Reinsurance Market Briefing at the 2019 Rendez-Vous de Septembre (Rendez-Vous) on Sunday, 8 September 2019, at the Hermitage Hotel in Monte Carlo, Monaco. The briefing will start at 10:15 a.m. and conclude at 11:45 a.m. (CEST).
As the leading open-invitation market presentation event at Rendez-Vous, this briefing is a unique opportunity for reinsurance market insight and opinion ahead of busy conference meeting schedules. AM Best senior management and analytical personnel from the rating agency’s international offices also will be participating in bilateral meetings throughout the conference.The briefing will highlight AM Best’s perspective on the global reinsurance market. Agenda topics include:
AM Best’s trend analysis on the global reinsurance sector;
Global reinsurance outlook and the drivers of future rating movements;
Capital management challenges;
Impact of alternative capital and insurance linked-securities; and
Key rating issues impacting all reinsurers.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Emerging Trends, Drivers and Challenges in the Olive Oil Market 2019–2023

Posted by fidest press agency su giovedì, 15 agosto 2019

The global olive oil market size is poised to grow by 485.64 thousand tons during 2019-2023, according to a new report by Technavio, progressing at a CAGR of more than 3% during the forecast period.
Technavio has published a new market research report on the global olive oil market from 2019-2023. Read the 125-page research report with TOC on “Olive Oil Market Analysis Report by application (culinary usage and other purposes) and geography (MEA, APAC, Europe, North America, and South America) 2019 – 2023” at https://www.technavio.com/report/global-olive-oil-market-industry-analysis? The rising use of olive oil in different sectors is anticipated to boost the growth of the olive oil market.The demand for olive oil is growing at a rapid pace across the world, mainly due to its health benefits. Olive oil is a unique and tasty alternative to conventional edible oils. The consumption of olive oil reduces inflammation as it is a rich, concentrated source of monosaturated fat called the oleic acid. It also protects against type 2 diabetes and is an effective treatment for rheumatoid arthritis. Such health benefits of olive oil are expected to significantly drive the growth of the global olive oil market size during the forecast period. Olive oil is also being used for various applications across different sectors. They are used for consumer products such as skin care creams, hair oils, snacks, daily products, and others. Pharmaceutical manufacturers are increasingly incorporating olive oil in medicines, owing to its health benefits. Thus, the growing use of olive oil in different sectors will fuel the growth of the market during the forecast period.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

New Tool From PredictX Drives Air Market Data Transparency

Posted by fidest press agency su martedì, 6 agosto 2019

Advanced analytics software provider, PredictX, releases an analytical solution answering the common pain points experienced by buyers during the air supplier sourcing and management process. The PredictX Navigator uses machine learning, advanced analysis and predictive analytics to guide or “navigate” buyers through multiple RFPs, existing contracts and the disruptive air marketplace we see today.The PredictX Navigator automatically analyzes and compares each proposal, contract and proposal iteration against other proposals and market rates. Navigator is able to track the performance of multiple contracts to both fixed and dynamic targets. Automated alerts guide the user on what decisions are mathematically best to make on each RFP and existing supplier contract.Navigator aids the buyer in a changing marketplace by providing not only current rates but future rates that result from the supplier management and sourcing decisions we make today. Starting with a fair market share analysis, travel buyers can use aviation data like service frequency, aircraft and route type to analyze and predict demand and the associated fares across routes and schedules. It automatically benchmarks each rate and outcome against current air market rates. These insights will allow buyers to see the overall quality of each deal in every situation – both now and in the future.The application is “NDC-ready” designed from the ground up for customers and carriers who embrace the new distribution content while also catering to those who are not yet NDC compliant. The tool allows for automated data consolidation between the old data formats and the new XML-based data transmission format.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

“US Phenylketonuria Market and Competitive Landscape – 2019”

Posted by fidest press agency su lunedì, 22 luglio 2019

This latest research provides comprehensive insights into Phenylketonuria pipeline products, Phenylketonuria epidemiology, Phenylketonuria market valuations and forecast, Phenylketonuria drugs sales and competitive landscape in the US.The research is classified into seven sections – Phenylketonuria treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.Phenylketonuria pipeline: Find out the products in clinical trials for the treatment of Phenylketonuria by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
Phenylketonuria epidemiology: Find out the number of patients diagnosed (prevalence) with Phenylketonuria in the US
Phenylketonuria drugs: Identify key products marketed and prescribed for Phenylketonuria in the US, including trade name, molecule name, and company
Phenylketonuria drugs sales: Find out the sales revenues of Phenylketonuria drugs in the US. Phenylketonuria market valuations: Find out the market size for Phenylketonuria drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
Phenylketonuria drugs market share: Find out the market shares for key Phenylketonuria drugs in the US.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Europe’s Second-Largest Medical Cannabis Market

Posted by fidest press agency su giovedì, 11 luglio 2019

EMMAC Life Sciences Ltd, the European independent medical cannabis company, is pleased to announce that it has formed a 50/50 joint venture company, Fontana S.R.L. (“Fontana JVCo”), with Sergio Fontana, the founder and major shareholder of Farmalabor S.R.L. (“Farmalabor”), one of Italy’s most active licensed importers and distributors of medical cannabis. Fontana S.R.L. has already submitted applications for licenses to import, store, manufacture and distribute medical cannabis products in Italy, which is the second-largest medical cannabis market in Europe. Pending the grant of such licences, Fontana JVCo will work with Farmalabor as its exclusive partner to commercialise medical cannabis and wellness products as well as commence operations and sales in Italy.The partnership positions Fontana S.R.L. as Farmalabor’s dedicated cannabis partner. Fontana JVCo combines Farmalabor’s existing medical cannabis sales and operations, pharmacy network and expertise within Italy with EMMAC’s industry expertise and integrated supply chain for cultivation and manufacturing. The partnership agreement with Farmalabor will provide Fontana JVCo with sales services, including distribution to 12,000 pharmacies. It is expected Fontana JVCo has the potential to rapidly establish itself as the largest supplier of medical cannabis and wellness products in Italy.

 

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Cougar Acquires Advanced Technology Aircraft to Fill Market Gap

Posted by fidest press agency su mercoledì, 3 luglio 2019

Cougar Aircraft Corp has acquired the assets of the GA-7 Cougar light twin aircraft, designed and formerly produced by Grumman Gulfstream, famous for military and executive jets. Cougar now owns the FAA Type Certificate A17SO, the technology, production tools, and world-wide rights needed to build this aircraft. The GA-7 is a perfect solution to fill the urgent need in the training market, and with its robust construction can handle the real-life flight testing required to advance to the next stages in alternative propulsion.The aviation training market has exploded with airline demand, and it is forecast that training over 800,000 pilots worldwide will generate a need for thousands of new planes. That adds up to potential sales of over $7 Billion USD. Market demand to produce new training planes has increased so much the one major light plane maker has revealed a 700-plane backorder and $350 million in annual turnover.The GA-7 is a proven and respected aircraft that offers a safe and profitable training platform; what’s more, modified GA-7s have already flown with alternative powerplants. The GA-7 uses advanced fighter jet construction derived from its Grumman heritage, combined with simple modular assembly, allowing for low cost, high volume production of new aircraft. As an added bonus, the GA-7 offers an exceptionally long service life of its main wing components at 42,000 hours – compared to a typical 12,000-hour service life. This means many more profitable flight hours and less frequent aircraft fleet replacements.The GA-7 could become the first and perhaps only light twin manufactured in China. Acquisition of an existing Type Certificate, which is valid forever, can save 10 years and many millions of dollars compared with development of a new, unproven aircraft model. With both single and twin-engine aircraft models and a 5,000 square meter facility ready to start production immediately, this is a golden opportunity for Chinese participation in aircraft manufacturing at a fraction of the usual cost of entry.Cougar Aircraft Corp is now inviting investors and suppliers to participate in their exclusive FAA and CAAC world-wide rights to bring these aircraft to a global market that is clearly in need of many more airplanes.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Best’s Market Segment Report: Positive Momentum for Russia’s Insurance Market

Posted by fidest press agency su mercoledì, 3 luglio 2019

Following a period of challenge, Russia’s insurance market appears to have reached a turning point with more diversified premium growth and better profitability reported in 2018, according to a new AM Best report. Nevertheless, in AM Best’s view, the recovery is fragile, and threats remain that could adversely impact market development and performance in the medium term.The Best’s Market Segment Report, titled “Positive Momentum for Russia’s Insurance Market, but Threats Remain,” states that development of Russia’s insurance market has been tempered in recent years by geopolitical instability, economic stagnation and the weak performance of the compulsory motor third-party liability segment. At the same time, more stringent oversight from the country’s insurance regulator, the Central Bank of Russia (CBR), has led to a reduction in the number of market participants, as smaller (re)insurers have been unable to withstand the increase in regulatory scrutiny.In 2018, the market’s total insurance premiums rose by approximately 16%, to RUB 1.48 trillion (USD 23 billion), according to the CBR. Notably, the uptick in gross written premiums was supported not just by growth in the life insurance business, but by higher income from non-life products as well. In terms of profitability, Russian insurers benefited from solid investment returns and improved combined ratios.The report also notes that at year-end 2018, 199 insurers were operating in Russia, down from over 700 companies 10 years earlier. The number of participants has declined each year, as a result of higher regulatory capital requirements, more stringent regulatory oversight and the voluntary exit of some companies. As a result of tougher conditions and a number of mergers and acquisitions, the market has also become more concentrated.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

“US Gout Market and Competitive Landscape – 2019”

Posted by fidest press agency su venerdì, 28 giugno 2019

The report has been added to ResearchAndMarkets.com’s offering.This latest research provides comprehensive insights into Gout pipeline products, Gout epidemiology, Gout market valuations and forecast, Gout drugs sales and competitive landscape in the US.
The research is classified into seven sections- Gout treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.Gout pipeline: Find out the products in clinical trials for the treatment of Gout by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
Gout epidemiology: Find out the number of patients diagnosed (prevalence) with Gout in the USGout drugs: Identify key products marketed and prescribed for Gout in the US, including trade name, molecule name, and companyGout drugs sales: Find out the sales revenues of Gout drugs in the US Gout market valuations: Find out the market size for Gout drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
Gout drugs market share: Find out the market shares for key Gout drugs in the US

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »